Edwards Lifesciences (EW) Tops Q4 EPS by 2c, Guides In-line for Q1 and FY09
Tweet Send to a Friend
Edwards Lifesciences (NYSE: EW) reports Q4 EPS of $0.78 (ex-items), 2 cents better than the analyst estimate of $0.76. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
